血管内皮生长因子 (VEGF) 家族和免疫系统:激活剂还是抑制剂?
Cristina Maria Failla1, Maria Luigia Carbone2, Carmela Ramondino1
1Experimental Immunology Laboratory, Istituto Dermopatico dell'Immacolata, IDI-IRCCS, 00167 Rome, Italy.
Biomedicines
|January 25, 2025
概括
血管内皮生长因子 (VEGFs) 对于血管形成至关重要,由免疫细胞产生. 用于瘤血管生成的VEGF抑制剂在组合疗法中显示出增强T细胞对癌症免疫力的潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 血管内皮生长因子 (VEGFs) 是血管生成和血管生成的关键调节者.
- 多种细胞类型分泌VEGF,包括免疫细胞,以应对各种刺激.
- 免疫细胞表达VEGF受体,使得对VEGFs的自身分泌和副分泌反应成为可能.
研究的目的:
- 审查目前对VEGFs与免疫系统之间的相互作用的理解.
- 探索VEGF抑制剂与免疫疗法结合的潜力.
- 确定关于VEGF和免疫反应的未来研究领域.
主要方法:
- 对VEGF,血管新生和免疫学研究的文献综述.
- 对VEGF家族成员免疫功能的分析.
- 对癌症治疗中VEGF抑制剂的临床前和临床数据的评估.
主要成果:
- 在调节免疫细胞功能和贩运中,VEGFs起着重要作用.
- VEGF信号传递可以抑制抗瘤免疫反应.
- 当与免疫疗法相结合时,VEGF抑制剂显示出增强抗瘤免疫力的潜力.
结论:
- VEGFs的免疫作用提供了新的治疗机会.
- 将VEGF抑制剂与免疫疗法结合使用可能会提高癌症治疗的疗效.
- 需要进一步的研究来优化针对VEGF和免疫系统的组合策略.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Mechanism of Angiogenesis
5.2K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.2K
Overview of the Vascular System
2.7K
The vascular system comprises an extensive network of arteries, capillaries, and veins. The vascular system can be broadly divided into the blood and lymphatic systems. Typically, blood vessels can be categorized into three histological regions: tunica intima, tunica media, and tunica adventitia. The tunica intima consists of a single layer of endothelial cells attached to the basal lamina. Underlying the basal lamina is a connective tissue layer and an elastic lamina that gives stability and...
2.7K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K


